Skip Navigation LinksHome > October 2013 - Volume 13 - Issue 5 > Is visual function affected in severe ocular allergies?
Current Opinion in Allergy & Clinical Immunology:
doi: 10.1097/ACI.0b013e328364ec7a
EYE ALLERGY: Edited by Leonard Bielory and Stefano Bonini

Is visual function affected in severe ocular allergies?

Leonardi, Andreaa; Bonini, Stefanob

Collapse Box

Abstract

Purpose of review

The purpose of the present review is to provide an overview on the clinical features and long-term complications of severe ocular allergies, with a special focus on the corneal involvement observed in these diseases, which may impair vision permanently. Furthermore, different treatment options are discussed based on the sight-threatening effects of corticosteroid use.

Recent findings

Recent data on the demographics, clinical and immunologic features of vernal and atopic keratoconjunctivitis are presented and discussed, and the evidence of a lack of literature addressing the issue of visual outcome in allergic diseases is underlined. The efficacy and possible long-term complications of their treatments are described, including visual impairment.

Summary

Diagnosis and treatment of patients with severe ocular allergy is a challenge for ophthalmologists due to the long-term corneal complications and the potential side-effects of topical corticosteroids that may induce cataract formation and glaucoma, and impair vision permanently. The review describes old and new concepts of management and possible complications such as severe, vision-threatening forms of allergic ocular disease. An update on their management and long-term complications may help clinicians to establish a common agreement on treatment options and researchers to design future studies based on similar outcomes, including visual acuity.

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.